Join the SUNSCAPE Study Program—A Series of Phase 3 Clinical Trials for People with Moderately to Severely Active Ulcerative Colitis (UC)

Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!

Open to people ages 16-80

• Participants aged ≥18 and ≤80 years of age at Screening. Where permitted locally, participants 16 to <18 years of age who meet the definition of Tanner Stage 5 for development
• Confirmed diagnosis of moderately to severely active UC for at least 3 months prior to Baseline
• Demonstrated inadequate response, have shown loss of response or intolerance to conventional therapies or advanced therapies

• Participants with Crohn's Disease (CD), indeterminate colitis
• Current diagnosis of Ulcerative Proctitis
• Participants with surgical bowel resection within the past 3 months prior to Baseline, or a history of >3 bowel resections
• Prior or current high-grade gastrointestinal (GI) dysplasia
• Participants on treatment with but not on stable doses of conventional therapies prior to baseline
• Participants with prohibited medications or therapies prior to baseline
• Participants with previous exposure to anti-TL1A investigational therapy The above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.